Those who took GLP-1s had an 11% reduced risk of dementia, compared to those who did not take the drug
Daneshpour N, Griffin M, Collighan R, Perrie Y (2011) Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis
GLP-1 agonists, which primarily target extrahepatic mechanisms to ameliorate metabolic disorders, when used in conjunction with resmetirom, focusing on intrahepatic mechanisms, offer a complementary approach in the management of MASH and liver fibrosis
Journal of Pharmaceutical and Biomedical Analysis (2021) 4
Repeated injections at the same point may result in unnecessarily reddening the skin
All handling must comply with local safety regulations.